Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:administrativeDivision |
Intravenous
Oral Varies based on condition |
| gptkbp:availability |
Available in powder form
Available as a supplement Available in capsule form |
| gptkbp:chemicalFormula |
Butyric acid salt
C4H7NaO2 |
| gptkbp:clinicalTrials |
Investigated for Crohn's disease
Investigated for autism spectrum disorders Investigated for colorectal cancer Investigated for metabolic syndrome Investigated for ulcerative colitis |
| gptkbp:composedOf |
Can be produced biologically
Can be synthesized chemically |
| gptkbp:dissolved |
Soluble in water
|
| gptkbp:environmentalImpact |
Biodegradable
Low toxicity to aquatic life |
| gptkbp:hasFacilities |
94.1_g/mol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sodium Butyrate
|
| gptkbp:impact |
Anti-inflammatory properties
Promotes gut health Histone deacetylase inhibitor May improve insulin sensitivity Potential neuroprotective effects |
| gptkbp:locatedIn |
20th century
|
| gptkbp:market |
Used in pharmaceuticals
Used in animal feed Used in food industry as a flavoring agent |
| gptkbp:patentCitation |
Several patents related to its use
|
| gptkbp:producedBy |
Fermentation of dietary fibers
|
| gptkbp:relatedPatent |
Calcium butyrate
Potassium butyrate Butyric_acid |
| gptkbp:researchAreas |
Cancer research
Metabolic disorders Neurodegenerative diseases Gut microbiome studies |
| gptkbp:safety |
Generally_recognized_as_safe_(GRAS)
|
| gptkbp:sideEffect |
Diarrhea
Nausea Flatulence Gastrointestinal discomfort |
| gptkbp:storage |
Store in a cool, dry place
|
| gptkbp:triggerType |
Enhances butyrate production in the gut
Inhibits histone deacetylases Modulates_gene_expression |
| gptkbp:uses |
Dietary supplement
Short-chain fatty acid |